Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Ford

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Oncogene|June 28, 2011
Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell propertiesS M Farabaugh, D S Micalizzi, P Jedlicka, et al.
Clinical Rehabilitation|June 2, 2001
Developing a disease-specific quality of life measure for people with multiple sclerosisH L Ford, E Gerry, A Tennant, et al.
Journal of Mammary Gland Biology and Neoplasia|April 24, 2020
Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasisM U J Oliphant, Deguang Kong, Hengbo Zhou, et al.
Biochemistry|January 24, 1998
Effect of Mts1 on the structure and activity of nonmuscle myosin IIH L Ford, D L Silver, B Kachar, et al.
Oncogene|May 15, 2012
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeuticsL Y Dimberg, C K Anderson, R Camidge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Transcriptional analysis of the mts1 gene with specific reference to 5' flanking sequencesE Tulchinsky, H L Ford, D Kramerov, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1998
Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesisH L Ford, E N Kabingu, E A Bump, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 1998
The prevalence of multiple sclerosis in the Leeds Health AuthorityH L Ford, E Gerry, C M Airey, et al.
Cancer Research|February 17, 2000
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancerR J Guan, H L Ford, Y Fu, et al.
The Journal of Biological Chemistry|May 10, 2000
Cell cycle-regulated phosphorylation of the human SIX1 homeodomain proteinH L Ford, E Landesman-Bollag, C S Dacwag, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncogene|June 28, 2011
Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell propertiesS M Farabaugh, D S Micalizzi, P Jedlicka, et al.
Clinical Rehabilitation|June 2, 2001
Developing a disease-specific quality of life measure for people with multiple sclerosisH L Ford, E Gerry, A Tennant, et al.
Journal of Mammary Gland Biology and Neoplasia|April 24, 2020
Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasisM U J Oliphant, Deguang Kong, Hengbo Zhou, et al.
Biochemistry|January 24, 1998
Effect of Mts1 on the structure and activity of nonmuscle myosin IIH L Ford, D L Silver, B Kachar, et al.
Oncogene|May 15, 2012
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeuticsL Y Dimberg, C K Anderson, R Camidge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Transcriptional analysis of the mts1 gene with specific reference to 5' flanking sequencesE Tulchinsky, H L Ford, D Kramerov, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1998
Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesisH L Ford, E N Kabingu, E A Bump, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 1998
The prevalence of multiple sclerosis in the Leeds Health AuthorityH L Ford, E Gerry, C M Airey, et al.
Cancer Research|February 17, 2000
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancerR J Guan, H L Ford, Y Fu, et al.
The Journal of Biological Chemistry|May 10, 2000
Cell cycle-regulated phosphorylation of the human SIX1 homeodomain proteinH L Ford, E Landesman-Bollag, C S Dacwag, et al.
Pageof 4